ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Crescent Capital BDC Inc

Crescent Capital BDC Inc (CCAP)

19.59
0.13
(0.67%)
Closed January 24 4:00PM
19.59
0.00
(0.00%)
After Hours: 4:45PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
19.59
Bid
19.34
Ask
19.70
Volume
45,140
19.50 Day's Range 19.6199
15.91 52 Week Range 20.03
Market Cap
Previous Close
19.46
Open
19.50
Last Trade Time
Financial Volume
$ 882,792
VWAP
19.5568
Average Volume (3m)
105,649
Shares Outstanding
37,061,547
Dividend Yield
8.58%
PE Ratio
8.65
Earnings Per Share (EPS)
2.26
Revenue
184.13M
Net Profit
83.84M

About Crescent Capital BDC Inc

Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital apprecia... Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies. Show more

Sector
Unit Inv Tr, Closed-end Mgmt
Industry
Unit Inv Tr, Closed-end Mgmt
Headquarters
Wilmington, Delaware, USA
Founded
-
Crescent Capital BDC Inc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the NASDAQ with ticker CCAP. The last closing price for Crescent Capital BDC was $19.46. Over the last year, Crescent Capital BDC shares have traded in a share price range of $ 15.91 to $ 20.03.

Crescent Capital BDC currently has 37,061,547 shares outstanding. The market capitalization of Crescent Capital BDC is $721.22 million. Crescent Capital BDC has a price to earnings ratio (PE ratio) of 8.65.

CCAP Latest News

Crescent Capital BDC, Inc. Reports Third Quarter 2024 Earnings Results; Declares a Fourth Quarter Base Dividend of $0.42 Per Share, and a Third Quarter Supplemental Dividend of $0.07 Per Share

LOS ANGELES, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.64 per share and net income of...

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Third Quarter Ended September 30, 2024 Financial Results

LOS ANGELES, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the third quarter ended...

Rumble Shares Up 7% in Premarket After 27% Q2 Revenue Surge; More on Earnings

Rumble Inc (NASDAQ:RUM) – Rumble, a video and digital content platform, reported a 27% sequential revenue growth, reaching $22.5 million in the second quarter of 2024. Monthly active users...

Crescent Capital BDC, Inc. Reports Second Quarter 2024 Earnings Results; Declares a Third Quarter Base Dividend of $0.42 Per Share, and a Second Quarter Supplemental Dividend of $0.09 Per Share

LOS ANGELES, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.59 per share and net income of...

U.S. Futures Steady as Markets Await Key Inflation Data, Oil Prices Climb

U.S. index futures are mostly unchanged in pre-market trading on Monday, as investors anticipate crucial inflation data. After a partial recovery from last week’s sharp drop, the market...

Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Second Quarter Ended June 30, 2024 Financial Results

LOS ANGELES, July 18, 2024 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the second quarter ended June...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.311.6078838174319.2819.7219.16941519.44295821CS
4-0.21-1.0606060606119.819.918.30029182819.23612833CS
121.347.3424657534218.2520.0317.4510564919.0974979CS
260.572.9968454258719.0220.0316.8510683818.67102584CS
522.9417.657657657716.6520.0315.9112658718.23070175CS
1561.8410.366197183117.7520.0312.5510918116.78941485CS
2603.0918.727272727316.521.48416.228335116.72106944CS

CCAP - Frequently Asked Questions (FAQ)

What is the current Crescent Capital BDC share price?
The current share price of Crescent Capital BDC is $ 19.59
How many Crescent Capital BDC shares are in issue?
Crescent Capital BDC has 37,061,547 shares in issue
What is the market cap of Crescent Capital BDC?
The market capitalisation of Crescent Capital BDC is USD 721.22M
What is the 1 year trading range for Crescent Capital BDC share price?
Crescent Capital BDC has traded in the range of $ 15.91 to $ 20.03 during the past year
What is the PE ratio of Crescent Capital BDC?
The price to earnings ratio of Crescent Capital BDC is 8.65
What is the cash to sales ratio of Crescent Capital BDC?
The cash to sales ratio of Crescent Capital BDC is 3.94
What is the reporting currency for Crescent Capital BDC?
Crescent Capital BDC reports financial results in USD
What is the latest annual turnover for Crescent Capital BDC?
The latest annual turnover of Crescent Capital BDC is USD 184.13M
What is the latest annual profit for Crescent Capital BDC?
The latest annual profit of Crescent Capital BDC is USD 83.84M
What is the registered address of Crescent Capital BDC?
The registered address for Crescent Capital BDC is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
Which industry sector does Crescent Capital BDC operate in?
Crescent Capital BDC operates in the UNIT INV TR, CLOSED-END MGMT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DWTXDogwood Therapeutics Inc
$ 13.2484
(373.16%)
103.21M
DGNXDiginex Ltd
$ 12.75
(70.00%)
9.74M
RNAZTransCode Therapeutics Inc
$ 5.61
(60.74%)
10.9M
EVAXEvaxion Biotech AS
$ 3.76
(57.98%)
4.02M
MCTRCTRL Group Ltd
$ 6.77
(56.35%)
8.84M
CHSNChanson International Holding
$ 0.83352
(-86.77%)
21.85M
ICONIcon Energy Corporation
$ 0.5348
(-59.18%)
15.88M
JUNSJupiter Neurosciences Inc
$ 1.50
(-58.10%)
11.08M
BACKIMAC Holdings Inc
$ 0.78
(-42.01%)
479.52k
DXSTDecent Holding Inc
$ 2.50
(-38.42%)
11.55M
HEPAHepion Pharmaceuticals Inc
$ 0.203
(50.37%)
538.53M
NVDANVIDIA Corporation
$ 147.22
(0.10%)
155.51M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.33095
(3.75%)
153.25M
RIMEAlgorhythm Holdings Inc
$ 0.0338
(1.81%)
137.59M
RGTIRigetti Computing Inc
$ 13.465
(-3.20%)
133.14M

Discussion

View Full Feed
weedtrader420 weedtrader420 5 minutes ago
XRP $6 TARGET 🌎🚀
XRPUSD
axelvento axelvento 6 minutes ago
Norovirus-A large phase three trial of the shot is underway, with results expected as soon as later this year or 2026. Moderna needs to see a certain number of cases before it can analyze the data and determine how well its vaccine works, putting the timeline in flux. The 25,000-person study is enro
MRNA
crescentmotor crescentmotor 8 minutes ago
My point was that the poster implied that Mayo has knowledge of M&A/ partnership discussions. Mayo clearly only assumes that because of his positive view of the drug's prospects.

Got you. Thanks for the clarification.
AVXL
surfer44 surfer44 14 minutes ago
Marianne Faithfull - Working Class Hero [1995] (Live)

https://youtu.be/yCn_6RBe0X4
surfer44 surfer44 16 minutes ago
Marianne Faithfull - Working Class Hero [1995] (Live)

https://youtu.be/yCn_6RBe0X4
lovethatgreen lovethatgreen 18 minutes ago
That w be 40k
AFFU
Konaploinks Konaploinks 18 minutes ago
Always I can’t wait for the first p r from Astra Zeneca and IonQ on their first breakthrough. Ya gotta know it’s coming. All aboard! Before the p r is released.
IONQ
wagner wagner 19 minutes ago
NioCorp Developments Ltd. is advancing the Elk Creek project in Nebraska, which focuses on niobium alongside titanium and scandium. NioCorp is collaborating with automakers to develop aluminum-scandium vehicle parts, highlighting scandium's strategic role in enhancing vehicle performance and sustain
NB
bwrbad bwrbad 20 minutes ago
interesting no posters in this
future $200 - $300 stock, and that future not far - see the quality of clinical data, target diseases, and the time it took to reach there - not standard 20 ys but 3y to ph3 and a large advancing failure resistant AI powered pipeline
RXRX
BDEZ BDEZ 21 minutes ago
CA Senate approves $25 Million for legal services for illegals

https://x.com/IanJaeger29/status/1882583700870963580
Konaploinks Konaploinks 22 minutes ago
Wiredawg. Good one.
Now is the time for the U.S. government to employ quantum computing and networking technologies to help address many of society’s complex challenges in areas such as security, finance, manufacturing and life sciences. We encourage a swift passage of this necessary legisla
IONQ
StockItOut StockItOut 23 minutes ago
They found a dilution partner.
SHOT
nedmorlef nedmorlef 26 minutes ago
Such strong and angry words. I've never met such a dysfunctional bunch on this website. One thing is for sure, you're all miserable human beings. Money can't change that for you.
FBEC
StockItOut StockItOut 27 minutes ago
To be clear, it's Xeriant's complaint against XTI.
XTIA
DMC8 DMC8 29 minutes ago
Recommendations for the
primary prevention of
atherosclerotic cardiovascular
disease in primary care: a
systematic guideline review
PUBLISHED 21 January 2025

https://www.researchgate.net/publication/388270501_Recommendations_for_the_primary_preventio
AMRN
skitahoe skitahoe 29 minutes ago
Barnstormer,

I believe that at the time of the halt in the trial all 4 regulators agreed to the changes that were used in completing the trial. I think they were working together on how trial protocols should be changed. These changes were largely reflected in the Journal article wr
NWBO
kayak_wench kayak_wench 30 minutes ago
Actually the regulation you cited does not explicitly prevent Vyvanse from being manufactured outside the United States.
The regulation (§1312.12) states that controlled substances in Schedules I and II cannot be imported into the U.S. unless the importer is properly registered and obtains a
ELTP
OPennyS OPennyS 32 minutes ago
ProphetMike or ProfitMike?
NWBO
kazzy kazzy 33 minutes ago
Another contrarian article outlining risks, though I don't see either as a major factor going forward.

https://news.oilandgaswatch.org/post/trump-order-on-liquefied-natural-gas-called-political-theater-and-optics

The only projects that were potentially slowed were four
TGLO
StockItOut StockItOut 34 minutes ago
I think you're a shmarmy pumper, hocking Xeriant as worthy of investment although unable and unwilling to recognize Xeriant's repeated multiple failures Xeriant's abandoned deals and its dissolved alliances.
XERI
BDEZ BDEZ 36 minutes ago
WEF Protein Bug Bars

https://x.com/RealAlexJones/status/1882523073460740399
DMC8 DMC8 36 minutes ago
https://stocktwits.com/SanDiegoLiving/message/601273518
AMRN
BDEZ BDEZ 37 minutes ago
Catholic leaders continue trashing Trump
ignatiusrielly35 ignatiusrielly35 38 minutes ago
Not at all. I am not saying that. My point was that the poster implied that Mayo has knowledge of M&A/ partnership discussions. Mayo clearly only assumes that because of his positive view of the drug's prospects. 

I would not be surprised if there are marketing and distribution deals
AVXL
BDEZ BDEZ 38 minutes ago
Can't blame them, ruined their lives.....

Your Recent History

Delayed Upgrade Clock